7.50
+0.15
+(2.04%)
At close: April 17 at 8:00:12 AM GMT+2
Key Executives
Key Executives Information Not Available
Oruka Therapeutics Inc. R
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Oruka Therapeutics Inc. R’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
April 23, 2025 at 10:59 AM UTC - April 28, 2025 at 12:00 PM UTC
Oruka Therapeutics Inc. R Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
05Y.MU Vivoryon Therapeutics NV
1.7140
0.00%
MVR0.BE Medivir AB
0.1372
-2.42%
BT3.BE Lineage Cell Therapeutics Inc
0.3600
-1.10%
HTD.MU Corcept Therapeutics Inc
57.90
-3.60%
DBV.F DBV Technologies S.A.
1.2520
+1.79%
PROT Proteonomix, Inc.
0.0000
0.00%
ICY.HA Incyte Corp
51.16
-0.31%
MVR0.F Medivir AB (publ)
0.1458
-1.88%
96X.F FluoGuide A/S
3.1700
0.00%
4FR.BE Faron Pharmaceuticals Oy
2.4400
+6.09%